A phase Ib, proof-of-concept trial of anatabine in patients with mild to moderate psoriasis

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Aug 2016 According to a Rock Creek Pharmaceuticals media release, initiation of this study is likely to be postponed from fourth quarter of 2016 to early first half of 2017.
16 May 2016 According to a Rock Creek Pharmaceuticals media release, the company expects to test therapeutic potential of anatabine in this study in Q4 of 2016.
15 Oct 2015 According to a Rock Creek Pharmaceuticals, Inc. media release, this trial is expected to commence in the first half of 2016.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com